Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 26, 2018
Comprehensive Analysis of the Relationship Between RAS and RAF Mutations and MSI Status of Colorectal Cancer in Northeastern ChinaWenqi Li, Huining Li, Ruiqi Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2021
Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable PeptideDan Hua, Lida Tang, Weiting Wang, et al.
Histology and Histopathology|December 10, 2019
Triptolide inhibits tonsillar IgA production by upregulating FDC-SP in IgA nephropathyHuining Li, Xinxin Yang, Guodong Yao, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 23, 2018
Prevalence and Prognostic Significance of HPV in Laryngeal Squamous Cell Carcinoma in Northeast ChinaFangjia Tong, Jingshu Geng, Bingqing Yan, et al.
Oncotarget|January 10, 2018
Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathyHuining Li, Dan Kong, Yangyang Xu, et al.
Frontiers in Neurology|September 25, 2020
Cortical Thinning and Ventricle Enlargement in Neuromyelitis Optica Spectrum DisordersDe-Cai Tian, Yuwen Xiu, Xinli Wang, et al.
Oncotarget|February 5, 2017
miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patientsHuining Li, Lin Yu, Jing Liu, et al.
Neuroscience Letters|January 28, 2015
miR-29s inhibit the malignant behavior of U87MG glioblastoma cell line by targeting DNMT3A and 3BHui Xu, Jing Sun, Cuijuan Shi, et al.
The Lancet Regional Health. Western Pacific|August 9, 2023
A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM studyZhiguo Li, Chao Zhang, Ting Chang, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Corrigendum to A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study Lancet Reg Health West Pac (2023) 38: 100846Zhiguo Li, Chao Zhang, Ting Chang, et al.
Pageof 5